Seema Verma
Showing 1–2 of 2 transcripts.
- Milken Institute47 min
Wednesday Lunch: Walking the Drug-Pricing Tightrope
Dan Diamond, Dan Leonard, Seema Verma, Matt Iles, Mark McClellan
Moderated by Dan Diamond, the Milken Institute's Future of Health Summit panel "Walking the Drug Pricing Tightrope" featured Seema Verma, Matt Iles, and Mark McClellan debating the tension between innovation and affordability amidst record-breaking drug costs. While the group reached consensus on shifting to value-based payment models to address unsustainable spending in Part B and high-cost curative therapies, they diverged on whether government negotiation or private sector competition offers the most effective solution for lowering prices without stifling future research. With Nancy Pelosi absent, the panelists emphasized that any viable legislative path must satisfy strict bipartisanship requirements to avoid jeopardizing patient access or long-term drug development pipelines.
- Milken Institute1h 22m
Toward a Healthier Future
Will Durant, Mike Milken, Tanisha Carino, Michael Milken, Francis Collins, Susan Desmond-Hellmann, Bernard J. Tyson, Seema Verma, Sue Desmond-Hellman
Representatives from the Gates Foundation, Kaiser Permanente, CMS, and NIH converged to outline a unified strategy shifting global health systems from reactive treatment toward proactive prevention and precision medicine. Leaders highlighted specific breakthroughs in gene therapy, AI-driven neural decoding, and data interoperability while proposing structural reforms to align financial incentives with long-term population wellness and disease eradication. The consensus among these major institutions emphasizes that future economic prosperity and reduced healthcare costs depend on integrating community infrastructure, digital infrastructure, and innovative financing models to address challenges ranging from mental health crises to rare genetic disorders.